Clinical Trial: Drug Screening of Pancreatic Cancer Organoids Developed From EUS-FNA Guided Biopsy Tissues

U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT03544255) titled 'Drug Screening of Pancreatic Cancer Organoids Developed From EUS-FNA Guided Biopsy Tissues' on April 17, 2018.

Brief Summary: We are going to establish "organoid" models from pancreatic cancer biopsies achieved via EUS-FNA. Then the sensitivity of the selected FDA-approved anti-cancer drugs will be tested in these organoids.

Study Type: Observational

Condition: * Pancreatic Cancer

* Pancreas Adenocarcinoma

Intervention: Procedure: Biopsy

Two extra EUS-FNA guided pancreatic biopsies collected for only research purposes.

Recruitment Status: Recruiting

Sponsor: Ying Lv

Information provided by (Responsible Party): Ying Lv, The A...